Education
About Us
Working with TipRanks
Follow Us
Terence Charles Budge Insider Profile
4 Followers
Terence Charles Budge, Director at Argenica Therapeutics Ltd, holds 805.70K shares in Argenica Therapeutics Ltd (Ticker: AU:AGN), holds 1.07M shares in Aspen Group Limited (Ticker: DE:AYV1).
Terence Charles Budge has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Terence Charles Budge holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Terence Charles Budge
Terence Charles Budge's Trading History
Argenica Therapeutics Ltd
Aug 08, 2024
Director
Uninformative Sell
95.45K
AU$161.14K
Aspen Group Limited
Oct 26, 2012
Senior Officer
Informative Buy
90.92K
€3.33M
List of latest transactions for each holding click on a transaction to see Terence Charles Budge's performance on stock
You May Also Like
Terence Charles Budge insider profile FAQ
What is the percentage of profitable transactions made by Terence Charles Budge?
The percentage of profitable transactions made by Terence Charles Budge is ―.
What is the average return per transaction made by Terence Charles Budge?
The average return per transaction made by Terence Charles Budge is ―.
What stocks does Terence Charles Budge hold?
Terence Charles Budge holds: AU:AGN, DE:AYV1 stocks.
What was Terence Charles Budge’s latest transaction?
Terence Charles Budge latest transaction was an Uninformative Sell of AU$95.45K.
What was Terence Charles Budge's most profitable transaction?
Terence Charles Budge’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Terence Charles Budge's role in Argenica Therapeutics Ltd?
Terence Charles Budge's role in Argenica Therapeutics Ltd is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.